17Aug
UK Life Sciences and Healthcare Newsletter - August 2020: COVID-19 – How Have Listed Companies Fared?
COVID-19 has had a significant financial impact on many listed companies and, in recent months, there has been a marked increase in equity capital raises by listed companies. As at 22 July 2020, there have been over 100 secondary equity fundraisings in excess of £10 million on the Main Market and AIM since the COVID lockdown period began. Some have had to raise emergency capital, on short notice and often at significant discounts, whereas others have sought to shore up their balance sheets as...
By:
Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-82301/
Related
Q: What is the current rule on whether an employee can use our company’s email system to distribute...
Read More >
Seyfarth Synopsis: Over the last few years, Illinois companies have quickly become aware of the risk...
Read More >
Globally, many developers and contractors are scrambling to identify available contractual relief as...
Read More >
2019 brought continuing changes to employment law issues affecting the health care industry. The fol...
Read More >
Various changes to employment law are coming into force over the next few months which should prompt...
Read More >
The Massachusetts Department of Family and Medical Leave (“DFML”) continues to provide ongoing sub...
Read More >